Novel recurrent somatic mutations in the core promoter region of TERT were recently identified in ~ 70% of melanoma samples examined by next-generation sequencing, which have now become the most frequently detected mutation in malignant melanoma (Horn et al. 2013; Huang et al. 2013). The gene discussed is TERT; the disease is melanoma.